Testosterone and depression: small average mood effects are not an antidepressant guarantee
Trials report small average improvements in depressive symptoms for some men, but testosterone is not a universal depression treatment. Review who was studied.

Testosterone may produce small average mood improvements in some hypogonadal men, but major depression requires its own assessment and evidence-based treatment.
Symptoms overlap heavily
Low mood, fatigue, poor concentration, sleep change, reduced libido, and loss of motivation can occur in depression and testosterone deficiency. Chronic pain, sleep apnea, thyroid disease, anemia, medication effects, alcohol, and major stress can produce the same cluster.
Overlap makes a careful history more important; it does not allow symptoms to diagnose a hormone problem. Endocrine guidance requires compatible signs or symptoms plus consistently low, accurately measured testosterone. Depression screening and safety assessment should proceed on their own track.

The Testosterone Trials found a modest signal
In symptomatic men age 65 or older with testosterone below 275 ng/dL, one year of testosterone gel produced slightly better mood and lower depressive-symptom severity than placebo. It did not improve the trial’s primary vitality outcome.
The distinction between mood and vitality matters because advertising often combines them into a promise of restored drive. A statistically significant average difference may be too small for some individuals to notice and does not show that treatment resolves a depressive disorder.
Meta-analysis found a small average effect
A meta-analysis of 27 randomized placebo-controlled trials involving 1,890 men found a small reduction in depressive symptoms with testosterone. Effects varied among studies, and meta-regression suggested that dose and baseline symptom variability influenced results.
The authors called for preregistered trials designed specifically around depression. Many included studies treated depressive symptoms as a secondary outcome, enrolled mixed populations, or used different testosterone thresholds and regimens. Pooling them improves statistical power but does not make them one uniform clinical population.
TRAVERSE did not show a large antidepressant effect
In the TRAVERSE depression analysis, testosterone produced modest improvements in mood and energy among men with hypogonadism and depressive symptoms. The subgroup meeting strict criteria for persistent depressive disorder was small, and no significant treatment difference appeared there.
Sleep quality and cognition did not improve. This pattern supports a narrow interpretation: testosterone can slightly shift symptom scores in some hypogonadal men, but it has not replaced psychotherapy, antidepressants, or other established treatments for a diagnosed depressive disorder.

Safety cannot wait for a hormone workup
Suicidal thoughts, inability to care for oneself, severe agitation, psychosis, or rapidly worsening depression requires urgent help. Waiting weeks for repeat morning testosterone tests is inappropriate when immediate psychiatric risk is present.
Testosterone can also affect irritability, sleep, acne, fertility, hematocrit, and other health domains. Starting it solely as a mood experiment without confirmed deficiency can expose a person to medical risks while delaying care that directly targets depression.
A more useful treatment question
Ask whether the man has confirmed hypogonadism with a symptom profile expected to respond, and whether depression has been independently assessed. Define what improvement would look like using a validated symptom scale, sexual symptoms, function, and adverse-effect monitoring.
If testosterone is appropriate for hypogonadism, a small mood benefit may be welcome. If testosterone is normal, the existing evidence does not support chasing higher levels as an antidepressant strategy. The honest promise is modest and population-specific, not a transformation in confidence or motivation.
Placebo response and regression to the mean matter
Mood symptoms fluctuate, and people often seek treatment when they feel worst. Scores may improve naturally over subsequent weeks, while the attention and expectations surrounding treatment create additional placebo response. Randomized trials are essential because a dramatic personal before-and-after story cannot separate these effects from the hormone.
Track depression with the same validated scale before and after treatment and record changes in sleep, alcohol, therapy, medication, exercise, and life stress. If several variables change together, credit cannot be assigned confidently to testosterone. The purpose is better care, not defending a favored explanation.
Families and partners can sometimes identify changes in sleep, irritability, risk-taking, or function that a symptom score misses. Their observations can add context, but treatment decisions should still use the patient’s consent, validated assessment, and a clinician’s evaluation rather than informal personality judgments.
Clinical context matters.
Sources & further reading
This article provides educational information. Ask a qualified clinician or pharmacist about your symptoms, medical conditions, medicines and supplement interactions.